EZH2 and myeloproliferative neoplasm: In mice models, the MPN phenotype induced by JAK2 V617F was accentuated in JAK2 V617F/EZH2 (wild type/wild type) mice, resulting in very high platelet and neutrophil counts, more advanced myelofibrosis, and reduced survival [70].